Adaptive Biotechnologies Corporation
ADPT
$9.29
-$0.22-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.24% | 3.66% | 22.46% | -11.72% | 11.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.24% | 3.66% | 22.46% | -11.72% | 11.23% |
| Cost of Revenue | -5.94% | 16.24% | -14.72% | 0.20% | -64.80% |
| Gross Profit | 48.87% | -7.05% | 156.28% | -22.69% | 274.71% |
| SG&A Expenses | -3.51% | -7.04% | -6.80% | -17.25% | -2.84% |
| Depreciation & Amortization | -0.95% | -0.23% | 0.00% | 0.24% | 0.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.48% | -11.08% | -11.04% | -13.89% | -4.43% |
| Operating Income | 39.29% | 25.86% | 35.96% | 16.11% | 14.74% |
| Income Before Tax | 37.24% | 51.46% | 36.22% | 3.27% | 17.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.24% | 51.46% | 36.22% | 3.27% | 17.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -184.62% | -3.85% | 0.00% | 2,500.00% | 2,500.00% |
| Net Income | 37.16% | 51.48% | 36.24% | 3.32% | 17.66% |
| EBIT | 39.29% | 25.86% | 35.96% | 16.11% | 14.74% |
| EBITDA | 42.88% | 26.98% | 37.95% | 16.73% | 15.88% |
| EPS Basic | 38.60% | 52.40% | 37.46% | 5.29% | 18.95% |
| Normalized Basic EPS | 39.93% | 26.57% | 37.48% | 20.06% | 16.80% |
| EPS Diluted | 38.60% | 52.40% | 37.46% | 5.29% | 18.95% |
| Normalized Diluted EPS | 39.93% | 26.57% | 37.48% | 20.06% | 16.80% |
| Average Basic Shares Outstanding | 2.34% | 1.92% | 1.94% | 2.09% | 1.59% |
| Average Diluted Shares Outstanding | 2.34% | 1.92% | 1.94% | 2.09% | 1.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |